Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) posted its earnings results on Thursday. The company reported ($2.74) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.71) by ($1.03), Zacks reports.
Cadrenal Therapeutics Stock Performance
CVKD stock opened at $19.09 on Friday. Cadrenal Therapeutics has a 1 year low of $5.40 and a 1 year high of $22.90. The firm has a market cap of $34.04 million, a P/E ratio of -2.86 and a beta of 1.40. The stock has a 50-day simple moving average of $18.31 and a 200-day simple moving average of $15.03.
About Cadrenal Therapeutics
Read More
- Five stocks we like better than Cadrenal Therapeutics
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- How to Use the MarketBeat Dividend Calculator
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
- Investing In Preferred Stock vs. Common Stock
- Why Costco Stock Is Poised to Hit $1,000 Again Soon
Receive News & Ratings for Cadrenal Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadrenal Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.